| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3284070 | Clinical Gastroenterology and Hepatology | 2010 | 8 Pages |
Abstract
Administration of 1 additional dose of certolizumab pegol to patients who relapsed on continuous maintenance therapy, and certolizumab pegol reinduction to those who relapsed after drug interruption, are effective strategies for treating patients who have relapsed after successful induction therapy with certolizumab pegol.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
William J. Sandborn, Stefan Schreiber, Stephen B. Hanauer, Jean-Frédéric Colombel, Ralph Bloomfield, Gary R. Lichtenstein, PRECiSE 4 Study Investigators PRECiSE 4 Study Investigators,